The European Commission has launched a public call for evidence on a targeted revision of EU rules for medical devices and in vitro diagnostics. The initiative aims to simplify regulatory requirements while ensuring patient safety, public health, and the availability of innovative devices
The revision seeks to make the EU medical device sector more competitive domestically and globally, support innovation, reduce dependencies, and ensure that safety requirements are cost-efficient and proportionate. This is an opportunity for the in silico medicine community to contribute individually and talking about acceptance of digital evidence.
Feedback is open until 6 October 2025 and will inform the Commissionā€™s adoption of the proposal, planned for Q4 2025.
If you are interested to contribute, full information can be found here
